LINC00635

Across TCGA pan-cancer cohorts, LINC00635 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC00635 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC00635 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00635 expression acts as an unfavorable survival marker, although some lineages such as KIRP and BLCA show a favorable association.

KIRP, BLCA, and COAD are the cancer types where LINC00635 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Quartile	II,III,IV	0.830	0.099	.001	66	view →
BLCA	OS	Median	All	0.698	0.555	.001	65	view →
COAD	OS	Tertile	IV	0.243	0.713	<.001	51	view →
SKCM	OS	Tertile	All	0.971	0.829	.002	45	view →
CESC	OS	Quartile	II,III,IV	0.528	0.798	.009	20	view →
ACC	OS	Tertile	III,IV	0.193	0.576	.020	16	view →
LIHC	DFS	Tertile	III,IV	0.173	0.626	<.001	16	view →
HNSC	DFS	Tertile	All	0.547	0.275	.016	15	view →
DLBC	DFS	Tertile	II,III,IV	1.000	0.377	.011	12	view →
PRAD	DFS	Tertile	All	0.931	0.737	.020	12	view →
CHOL	DFS	Tertile	All	1.000	0.256	.011	9	view →
LUSC	OS	Quartile	II,III,IV	0.801	0.607	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC00635–KIRP (DFS)

Open the KIRP breakdown →